Healthy Volunteers Clinical Trial
— ARGuideOfficial title:
THE INFLUENCE OF GRAVITY ON TARGET CUEING DURING VISUAL SEARCH USING AUGMENTED REALITY
Although most ground studies showed that an egocentric reference frame better supports
spatial orientation, it is not proven it will be the same during weightlessness.
Although it might justify that visuomotor performance will be better supported by egocentric
target cueing under altered gravity conditions, the fact that exocentric target cueing
induces less head movements and called for least attentional and physiological workload could
be the key factors for a more efficient task localization process. Moreover, weightlessness
can induce spatial disorientation, which can be additionally influenced by the intrinsic and
extrinsic spatial reference frames (Gurfinkel et al., 1993; Glasauer & Mittelstädt, 1997,
1998; Harm et al., 1998; Lipshits et al. 2005). We expect that during weightlessness the
workload will be the key factor and thus we hypothesize that an exocentric target cueing will
outperform egocentric target cueing.
To test this hypothesis, and find out which presentation scheme for target cueing (EGO, EXO,
ED) contributes most to an efficient visual search, performance to a visuomotor task will be
evaluated during parabolic flights in normogravity (1g), hypergravity (1.8g) and microgravity
(0g). The visuomotor performance will be assessed by a multi-directional tapping task as
defined by ISO9241-9, which requests for motor responses by aimed pointing movements. Besides
analyzing the pointing performance, different workload indices will be additionally assessed
to evaluate the effort spent on visuomotor coordination. The attentional workload will be
evaluated by the performance of a secondary task (visual reaction-time task), which needs to
be conducted in parallel to the visuomotor task. Furthermore, the workload will be also
assessed subjectively by the NASA TLX rating scale and physiologically, by analyzing the
heart rate variability (HRV).
Status | Recruiting |
Enrollment | 18 |
Est. completion date | December 31, 2019 |
Est. primary completion date | October 31, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 67 Years |
Eligibility |
Inclusion Criteria: - Healthy volunteers (men or women) - Aged from 18 to 67 - Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC) - Who accepted to take part in the study - Who have given their written stated consent - Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection. Exclusion Criteria: - Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated - Pregnant women |
Country | Name | City | State |
---|---|---|---|
France | CHU de Caen | Caen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | visuomotor performance | The visuomotor performance will be assessed by a multi-directional tapping task as defined by ISO9241-9, which requests for motor responses by aimed pointing movements. | baseline | |
Primary | common external display guidance method (ED) | common external display guidance method (ED) and exocentric "in-view" cueing (EXO), using common guidance method with an external display (ED) as a control condition | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |